Centre for Probe Development and Commercialization
Hamilton
About Centre for Probe Development and Commercialization
CPDC specializes in radiopharmaceutical research and development. They develop imaging agents and targeted radiotherapeutics for the detection and treatment of human diseases. Their programs in the clinical, preclinical, and discovery stages target PSMA in prostate cancer and monitor immune responses, as well as various other cancer and neurology targets.
Company Facts
- Operating status: Active
- Company type: Non-Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $8.1M
- Last round: Grant (Aug 2018)
- Website: cpdc.ca
- Phone: [email protected]
Industries & Categories
Biotechnology, Pharmaceutical, Product Research, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/centre-for-probe-development-and-commercialization-126677 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.